|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Gap junction intercellular communication and carcinogenesis 显示文摘 | sulkowski S Sulkowska M Skrzydlewska E | 1999 | Pol J Pathol1999，，4： | 1 |
| 2 | Gap juntion intercellular communication and carcinogenesis 显示文摘 | Sulkowski S Sulkowska M Skrzydlewska E | 1999 | Pol J Pathol1999，，4： | 1 |
| 3 | Efficacy and safety of albinterferon alfa-2b in combination with ribavirin in treatment-naive,chronic hepatitis C genotype 1 (CHC Gl) patients显示文摘 | Zeuzem S Sulkowski M Lawitz E | | Journal of Hepatology0，，： | 1 |
| 4 | Effects of 2-(substituted-sulfanyl)-3,5-dihydro-imidazole-4-one and 2-(substituted-sulfanyl)-1H-imidazole-4,5-dione derivatives on serum HDL-cholesterol显示文摘 | E lokdah H Sulkowski T Cochran D | 2000 | Bioorg MedChem Lett2000，10，： | 1 |
| 5 | Elevated liver enzymes following initiation of antiretroviral therapy显示文摘 | Sulkowski M S Thomas D L Chaisson R E | 2000 | JAMA2000，283，19： | 1 |
| 6 | Comparison of morphological and biochemical changes of BAL-isolated cells in experimental lung emphysema显示文摘 | Sulkowska M Skrzydlewska E | 1995 | Pol J Pathol1995，46，3： | 1 |
| 7 | Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype l in non-responders to pegylated interferon and rihavirin and treatment-naive patients: the COSMOS randomised study显示文摘 | Lawitz E Sulkowski M S Ghalib R | 2014 | The Lancet2014，384，9956： | 1 |
| 8 | Gap junctional intercellular communication and carcinogenesis 显示文摘 | Sulkowski S Sulkowska M Skrzydlewska E | 1999 | Pol J Pathol1999，50，4： | 1 |
| 9 | Potent viral suppression with all - oral combination of daclatasvir ( NS5A inhibitor) and GS - 7977 (NS5B inhibitor), + / - ribavirin, in treatment - naive patients w ith chronic HCV GT 1, 2, or 3 显示文摘 | Sulkowski M S Gardiner D F Lawitz E | 2012 | J Hepatology2012，56，2： | 1 |
| 10 | High sustained virologic response rate in treatment - naive HCV genotype 1 a and 1 b pa- tients treated for 12 weeks with an interferon - free all - oral quad regi- men : interim resuhs 显示文摘 | Sulkowski M S Rodriguez- Tortes M Lawitz E | 2012 | J Hepatology2012，56，2： | 1 |
| 11 | Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patieats with HIV: a randomized trial 显示文摘 | Sulkowski M S Sherman K E Dieterich D T | 2013 | Annals of intemal medicine2013，159，2： | 1 |
| 12 | The effects of coumarins on the root elongation and ultrastructure of meristematic cell protoplast显示文摘 | Kupidlowska E Kowalec M Sulkowski G | 1994 | Ann Bot1994，73，： | 1 |
| 13 | Bonding of human interferons to immobilized Cibacron Blue F3GA:the nature of molecular interaction显示文摘 | Jankowski W J Muenchhausen W Sulkowski E | 1976 | Biochemistry1976，15，： | 1 |
| 14 | Purification of proteins by IMAC显示文摘 | | 1985 | Trends Biotechnol1985，3，： | 1 |
| 15 | Combina- tion therapy with telaprevir for chronic hepatitis C virus geno- type 1 infection in patients with HIV: a randomized trial 显示文摘 | Sulkowski M S Sherman K E Dieterich D T | 2013 | Ann Intern Med2013，159，2： | 1 |
| 16 | The saga of IMAC and MIT显示文摘 | | 1989 | Bioassays1989，19，： | 1 |
| 17 | Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepa-titis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study显示文摘 | Lawitz E Sulkowski MS Ghalib R | 2014 | Lancet2014，384，9956： | 1 |
| 18 | High rate of sustained virological response with all-oral combination of daclatasvir (NS5A inhibitor) plus sofosbuvir (nucleotide NS5B inhibitor), +/- ribavirin, in treatment naive patients with chronically infected with HCV genotype 1, 2 and 3 显示文摘 | Sulkowski M Rodriguez M Lawitz E | 2012 | Hepatology2012，，： | 1 |
| 19 | The effect ofcoumarins on root elongation and ultrastructure of Meristematic cell proto-plast显示文摘 | KUPIDLOWSKA E KOWALEC M SULKOWSKI G | 1994 | Annals of Botany1994，73，： | 1 |
| 20 | Simeprevirplus sofosbuvir, with or without ribavirin, to treat chronic in-fection with hepatitis C virus genotype 1 in non - respondersto pegylated interferon and ribavirin and treatment - naive pa-tients: the COSMOS randomised study显示文摘 | LAWITZ E SULKOWSKI MS GHALIB R | 2014 | Lancet2014，384，9956： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员